Insider Trading activities of Kempharm, Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kempharm, Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kempharm, Inc since year 2005. Table 2 shows the detailed insider transactions of Kempharm, Inc since 2005. The reporting company's ticker symbol is KMPH. The reporting company's CIK number is 1434647.
The total value of stock buying since 2005 is $1,357,342.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $61,998.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Kempharm, Inc (KMPH).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 326,188 $1,067,813 0 $0 0 $0
2017-08 9,000 $23,268 0 $0 0 $0
2017-06 8,275 $28,499 0 $0 0 $0
2017-05 2,500 $10,305 0 $0 0 $0
2017-03 8,500 $36,046 0 $0 0 $0
2016-11 5,000 $17,440 0 $0 0 $0
2016-09 10,000 $47,471 0 $0 0 $0
2016-08 10,000 $49,500 0 $0 0 $0
2016-04 0 $0 0 $0 13,333 $61,998
2015-04 7,000 $77,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Kempharm, Inc insiders (KMPH)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-25 Clifton R. Laduane (CFO, Secretary & Treasurer) Buy 300 3.77 1,132
2017-09-14 Bluhm Andrew G (10% Owner) Buy 138,857 3.30 458,644
2017-09-13 Bluhm Andrew G (10% Owner) Buy 187,031 3.25 608,037
2017-08-24 Cohen Daniel L (EVP, Govt. & Public Relations) Buy 5,000 2.58 12,880
2017-08-24 Johnson Gordon K (Chief Business Officer) Buy 4,000 2.60 10,388
2017-06-20 Mickle Travis C (President & CEO) Buy 8,000 3.45 27,592
2017-06-19 Clifton R. Laduane (CFO, Secretary & Treasurer) Buy 275 3.30 907
2017-05-25 Cohen Daniel L (EVP, Govt. & Public Relations) Buy 2,500 4.12 10,305
2017-03-31 Cohen Daniel L (EVP, Govt. & Public Relations) Buy 1,000 4.70 4,700
2017-03-29 Cohen Daniel L (EVP, Govt. & Public Relations) Buy 1,500 4.33 6,502
2017-03-24 Clifton R. Laduane (CFO, Secretary & Treasurer) Buy 1,000 4.24 4,244
2017-03-22 Mickle Christal M M (VP, Operations & Product Dvlp.) Buy 2,000 4.10 8,200
2017-03-22 Mickle Travis C (President & CEO) Buy 2,000 4.10 8,200
2017-03-20 Tierney David S (Director) Buy 1,000 4.20 4,200
2016-11-30 Cohen Daniel L (EVP, Govt and Public Relations) Buy 5,000 3.49 17,440
2016-09-06 Cohen Daniel L (EVP, Govt and Public Relations) Buy 3,690 5.01 18,490
2016-09-02 Cohen Daniel L (EVP, Govt and Public Relations) Buy 6,310 4.59 28,981
2016-08-17 Mickle Christal M M (VP Prod Dev) Buy 5,000 4.95 24,750
2016-08-17 Mickle Travis C (President & CEO) Buy 5,000 4.95 24,750
2016-04-04 Thompson Danny L (Director) Option Ex 13,333 4.65 61,998
2015-04-21 Johnson Gordon K (COO & CFO) Buy 2,000 11.00 22,000
2015-04-21 Tierney David S (Director) Buy 5,000 11.00 55,000

Insider trading activities including stock purchases, stock sales, and option exercises of KMPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kempharm, Inc (symbol KMPH, CIK number 1434647) see the Securities and Exchange Commission (SEC) website.